# Randomized Clinical Trial Evaluating BP1.3656 Versus Placebo For Alcohol Use Disorder Treatment

> **NCT03424824** · PHASE2 · COMPLETED · sponsor: **Bioprojet** · enrollment: 210 (actual)

## Conditions studied

- Alcohol Use Disorder

## Interventions

- **DRUG:** BP1.3656 low dose
- **DRUG:** BP1.3656 intermediate dose
- **DRUG:** Placebo
- **DRUG:** BP1.3656 high dose

## Key facts

- **NCT ID:** NCT03424824
- **Lead sponsor:** Bioprojet
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-09
- **Primary completion:** 2021-11-24
- **Final completion:** 2021-11-24
- **Target enrollment:** 210 (ACTUAL)
- **Last updated:** 2022-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03424824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03424824, "Randomized Clinical Trial Evaluating BP1.3656 Versus Placebo For Alcohol Use Disorder Treatment". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03424824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*